MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
// Related Deep Analysis
Amgen Reports Positive Outcomes in Phase 3 Sjögren's Trial
Read the full analysis →
Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data
Trading Ideas
AMGN
Sep 22
AI-curated analysis for informational purposes only — not investment advice.
Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data
Read the full story at benzinga.com →